Elevated expression of adrenomedullin is correlated with prognosis and disease severity in osteosarcoma

Dai, Xing; Ma, Wei; He, Xijing; Jha, Rajiv
March 2013
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
Academic Journal
The treatment for osteosarcoma is a formidable challenge. Currently, treatment is not sufficiently effective, and new therapeutic targets are urgently needed. The aim of this study is to determine the expression of adrenomedullin (ADM) in human osteosarcoma tissue and to assess its effect on the proliferation of MG-63 cells and in vivo in an animal model of osteosarcoma. First, we collected clinical specimens from osteosarcoma patients and healthy controls and measured ADM expression by immunohistochemistry, RT-PCR, and radioimmunoassay. We also analyzed clinical data to investigate the relationship between ADM expression, malignancy, and tumor prognosis. Based on these data, we used RNA interference (RNAi) against ADM delivered by lentivirus vector transfected into the osteosarcoma cell line MG-63 to downregulate the expression of ADM. Finally, we observed the effect of ADM on the proliferation of MG-63 cells in vitro, and in vivo, in an animal model of osteosarcoma. We found that ADM was overexpressed in human osteosarcoma tissue, whereas expression was low in the adjacent tissue and little expression was observed in normal tissue. ADM RNAi significantly inhibited the proliferation of MG-63 cells. Therefore, the growth of osteosarcoma could be inhibited by decreasing the expression of ADM. Thus, we conclude that ADM expression is highly correlated with the degree of malignancy and metastasis of osteosarcoma.


Related Articles

  • Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma. Fujiwara-Okada, Y; Matsumoto, Y; Fukushi, J; Setsu, N; Matsuura, S; Kamura, S; Fujiwara, T; Iida, K; Hatano, M; Nabeshima, A; Yamada, H; Ono, M; Oda, Y; Iwamoto, Y // British Journal of Cancer;3/5/2013, Vol. 108 Issue 4, p836 

    Background:Prognosis of osteosarcoma (OS) with distant metastasis and local recurrence is still poor. Y-box binding protein-1 (YB-1) is a multifunctional protein that can act as a regulator of transcription and translation and its high expression of YB-1 protein was observed in OS, however, the...

  • Role of Extracellular Matrix Biopolymers in Proliferation of Human Osteosarcoma. Harisi, R.; Dudas, J.; Bocsi, J.; Szendroi, M.; Jeney, A. // European Surgical Research;May/Jun2004 Supplement 1, Vol. 36, p134 

    In this study involvement of extracellular matrix and its components in osteosarcoma cell proliferation and tumour progression was investigated. The clinical background of the biological investigation was a seventeen-year-old boy whose biopsy was with osteosarcoma diagnosed. His osteosarcoma...

  • LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy. XIN HUA LONG; ZHEN HAO ZHONG; AI FEN PENG; LIANG BO ZHU; HENG WANG; GUO MEI ZHANG; ZHI LI LIU // Molecular Medicine Reports;2014, Vol. 10 Issue 6, p2967 

    Pirarubicin is frequently used in chemotherapy against tumors. However, clinical use is severely limited by the development of progressive dose-dependent cardiomyopathy and acquired drug resistance. LY294002 is a commonly used pharmacologic inhibitor, which selectively inhibits the...

  • Sevoflurane Inhibited Osteosarcoma Cell Proliferation And Invasion Via Targeting miR-203/WNT2B/Wnt/β-Catenin Axis. Chen, Meixian; Zhou, Lisheng; Liao, Zhaoxia; Ye, Xijiu; Xuan, Xujun; Gu, Beibei; Lu, Fuding // Cancer Management & Research;Nov2019, Vol. 11, p9505 

    Background: Osteosarcoma is one of the most common primary bone cancers with predominant occurrence in children and adolescents. This study aimed to determine the effects of sevoflurane treatment on the osteosarcoma progression and to explore the underlying molecular mechanisms. Materials and...

  • miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells. HUICHENG LV; JUN GUO; SIQIN LI; DIANMIN JIANG // Experimental & Therapeutic Medicine;2014, Vol. 8 Issue 5, p1575 

    As the most common malignant primary bone tumor in childhood, osteosarcoma (OS) maintains a high recurrence, despite the significant improvements in the overall survival rate of high-grade OS patients during the recent decades. Therefore, a novel therapy strategy is required for OS treatment....

  • Suppression of Osteosarcoma Cell Invasion by Chemotherapy Is Mediated by Urokinase Plasminogen Activator Activity via Up-Regulation of EGR1. Matsunoshita, Yukihiro; Ijiri, Kosei; Ishidou, Yasuhiro; Nagano, Satoshi; Yamamoto, Takuya; Nagao, Hiroko; Komiya, Setsuro; Setoguchi, Takao // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Background: The cellular and molecular mechanisms of tumour response following chemotherapy are largely unknown. We found that low dose anti-tumour agents up-regulate early growth response 1 (EGR1) expression. EGR1 is a member of the immediate-early gene group of transcription factors which...

  • Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours. Tirino, Virginia; Desiderio, Vincenzo; d'Aquino, Riccardo; De Francesco, Francesco; Pirozzi, Giuseppe; Galderisi, Umberto; Cavaliere, Carlo; De Rosa, Alfredo; Papaccio, Gianpaolo // PLoS ONE;2008, Vol. 3 Issue 10, p1 

    Background: Osteosarcoma is the most common primary tumour of bone. Solid tumours are made of heterogeneous cell populations, which display different goals and roles in tumour economy. A rather small cell subset can hold or acquire stem potentials, gaining aggressiveness and increasing...

  • Proliferative activity (Ki-67 expression) and outcome in high grade osteosarcoma: a study of 27 cases. Jong, Roland; Davis, Aileen M.; Mendes, Maria G.; Wunder, Jay S.; Bell, Robert S.; Kandel, Rita // Sarcoma;Mar2000, Vol. 4 Issue 1/2, p47 

    Purpose. Although pre-operative chemotherapy has improved the prognosis for individuals with osteosarcoma, approximately 40% of patients will die of their disease. The aim of this study was to quantitate proliferative activity in high grade osteosarcomas and to determine whether proliferation is...

  • Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma. Xu, Haidong; Mei, Qiang; Xiong, Chengjie; Zhao, Jianning // Cell Biochemistry & Biophysics;Jun2014, Vol. 69 Issue 2, p319 

    Osteosarcoma is the most common primary malignancy to arise from bone. The pathogenesis of osteosarcoma is unclear, and new therapy molecular target is needed. The miRNAs researched suggested that miRNAs are involved in the pathogenesis of osteosarcoma. MiR-141, which belong to miR-200 family,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics